As the health tech market slowly picks back up, investors are thinking outside the box with ways to get their money back.
After a roller coaster of uncertainty in the markets earlier this year, most …
Lenz Therapeutics alarmed investors on Friday when it disclosed a report of a serious complication in a patient who took its commercial eye drop for
The FDA will consider more real-world data in drug and device applications, including from large datasets that don’t have identifiable patient data, Commissioner Marty Makary
Johnson & Johnson’s Tecvayli and Darzalex combination treatment scored another win in second-line multiple myeloma, with the FDA moving with unprecedented speed after the latest
The telehealth company Noom plans to target people with a body mass index well below the requirements for FDA-approved obesity shots, using a microdose GLP-1
As the health tech market slowly picks back up, investors are thinking outside the box with ways to get their money back.
After a roller coaster of uncertainty in the markets earlier this year, most …